Vaccibody AS (VACC): Share capital increase from exercise of warrants
2020-09-17 12:19:37
As a consequence of a holder of warrants having exercised a total of 836,000 warrants in Vaccibody AS, the share capital of Vaccibody AS will increase by NOK 8,360.00 from NOK 2,827,916.80 to NOK 2,836,276.80 from the time of registration with the Norwegian Register of Business Enterprises of the share capital increase related to the exercise of the warrants. The number of outstanding shares in the company will increase by 836,000 from 282,791,680 to 283,627,680, each with a par value of NOK 0.01.
The warrants exercised were the following:
Martin Bonde (former CEO): 770,000 warrants at strike 2.50 NOK/share and 66,000 warrants at strike 0.80 NOK/share.
After the exercise of these warrants, the total number of outstanding active warrants in the company is 15,538,930.